Cohort 2023↗
Aperture Bio
Combining the study of proteins and their functions to facilitate the development of cancer drugs.
← All companies
Cohort 2023
Providentia Technologies
Predicting drug toxicity early with synthetic cell membranes and machine learning algorithms.
Part of the Studio communityCohort 2023
Keep exploring
More from this cohort.
Cohort 2023↗
Ascent Bio
Optimizing the search for candidate molecules with a pretrained, deep learning, API-oriented platform.
Cohort 2023↗
Brainify.AI
Optimizing depression treatment through AI-driven precision psychiatry.
Connect with MDSS
Your next step starts
with a conversation.
Building a company, exploring the program or looking to contribute? Tell us what you have in mind.
Let’s talk Founders · Partners · Mentors